Hoth Therapeutics Inc (HOTH) — Cash Flow-to-Debt Ratio
Hoth Therapeutics Inc (HOTH) has a Cash Flow-to-Debt Ratio of -2.13x as of March 2026, meaning its operating cash flow of $-3.05 Million could theoretically repay -2% of its total liabilities ($1.43 Million) in one year. Explore investment intensity of Hoth Therapeutics Inc to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hoth Therapeutics Inc Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Hoth Therapeutics Inc across 9 annual periods. Also explore Hoth Therapeutics Inc balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Hoth Therapeutics Inc (2017–2025)
Year-by-year debt coverage analysis for Hoth Therapeutics Inc. For market capitalisation and broader financial context, see Hoth Therapeutics Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.75x | $-9.80 Million | $1.45 Million | ▲ +19.4% |
| 2024 | -8.37x | $-6.98 Million | $833.91K | ▲ +30.2% |
| 2023 | -11.98x | $-8.45 Million | $704.98K | ▼ -111.1% |
| 2022 | -5.68x | $-9.30 Million | $1.64 Million | ▲ +48.2% |
| 2021 | -10.96x | $-12.09 Million | $1.10 Million | ▼ -6.7% |
| 2020 | -10.27x | $-6.13 Million | $597.15K | ▲ +8.6% |
| 2019 | -11.24x | $-4.95 Million | $440.12K | ▼ -86.5% |
| 2018 | -6.03x | $-2.10 Million | $348.95K | ▲ +35.9% |
| 2017 | -9.41x | $-465.24K | $49.47K | — |